ESC Premium Access

Implications of new CV risk reduction indication of PCSK9 inhibitors - Focus on ODYSSEY outcomes

Congress Presentation

About the speaker

Professor Gaetano Maria De Ferrari

Hospital Molinette of the University Hospital S. Giovanni Battista/City University Hosp of Health an, Turin (Italy)
18 presentations
0 follower

Access the full session

Implications of new CV risk reduction indication of PCSK9 inhibitors - Focus on ODYSSEY outcomes

Speakers: Professor G. De Ferrari
Thumbnail

About the event

Image

ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb